Merus N.V. - stock earnings
MRUS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | - / -0.8300000000 | - | - / 9.7 million | - |
MRUS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -60.2 million USD | 8.9 million USD |
| 2023Q3 | -23.0 million USD | 11.0 million USD |
| 2023Q2 | -32.0 million USD | 10.5 million USD |
| 2023Q1 | -39.7 million USD | 13.5 million USD |
| 2022Q4 | -82.0 million USD | 10.7 million USD |
| 2022Q3 | -24.6 million USD | 6.6 million USD |
| 2022Q2 | -5.7 million USD | 12.7 million USD |
| 2022Q1 | -18.9 million USD | 11.7 million USD |
| 2021Q4 | -14.4 million USD | 14.7 million USD |
| 2021Q3 | -14.9 million USD | 13.7 million USD |
| 2021Q2 | -27.4 million USD | 12.4 million USD |
| 2021Q1 | -10.2 million USD | 8.4 million USD |
| 2020Q4 | -28.0 million USD | 9.0 million USD |
| 2020Q3 | -23.1 million USD | 8.6 million USD |
| 2020Q2 | -18.0 million USD | 6.1 million USD |
| 2020Q1 | -16.5 million USD | 6.3 million USD |
| 2019Q4 | -26.1 million USD | 7.7 million USD |
| 2019Q3 | -9.1 million USD | 9.0 million USD |
| 2019Q2 | -13.6 million USD | 6.5 million USD |
| 2019Q1 | -632578 USD | 9.7 million USD |
| 2018Q4 | -632578 USD | 9.7 million USD |
| 2018Q3 | -12.4 million USD | 7.6 million USD |
| 2018Q2 | -5.3 million USD | 7.4 million USD |
| 2018Q1 | -17.1 million USD | 4.6 million USD |
| 2017Q4 | -17.1 million USD | 4.6 million USD |
| 2017Q3 | -18.4 million USD | 4.0 million USD |
| 2017Q2 | -25.0 million USD | 3.7 million USD |
| 2017Q1 | -32.3 million USD | 1.2 million USD |
| 2016Q4 | -32.3 million USD | 1.2 million USD |
| 2016Q3 | -5.5 million USD | 1.0 million USD |
| 2016Q2 | -5.4 million USD | 213568 USD |
| 2016Q1 | -6.2 million USD | 63466 USD |
| 2015Q4 | -6.7 million USD | 21064 USD |
| 2015Q3 | -6.9 million USD | 109144 USD |
| 2015Q2 | -6.2 million USD | 1.2 million USD |
| 2015Q1 | -5.2 million USD | 60643 USD |
| 2014Q4 | -6.4 million USD | 477884 USD |
| 2014Q3 | -5.2 million USD | 397378 USD |
| 2013Q4 | -9.9 million USD | 769000 USD |
MRUS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -154.9 million USD | 43.9 million USD |
| 2022 | -131.2 million USD | 41.6 million USD |
| 2021 | -66.8 million USD | 49.1 million USD |
| 2020 | -85.5 million USD | 29.9 million USD |
| 2019 | -55.2 million USD | 31.1 million USD |
| 2018 | -27.8 million USD | 36.0 million USD |
| 2017 | -87.7 million USD | 14.9 million USD |
| 2016 | -49.7 million USD | 2.9 million USD |
| 2015 | -25.3 million USD | 1.4 million USD |
| 2014 | -21.2 million USD | 944841 USD |
| 2013 | -13.7 million USD | 260984 USD |
MRUS
Price: $45.11
52 week price:
Earnings Per Share: -3.00 USD
P/E Ratio: -10.23
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 272700
Ebitda: -11.8 millionMarket Capitalization: 2.6 billion